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a  b  s  t  r  a  c  t
Skull base tumors form a highly heterogeneous group. As there are several structures in
this  anatomical site, a large number of different primary malignancies might develop, as
well  as a variety of secondary (metastatic) tumors. In this article, the most common malig-
nancies are presented, along with a short histopathologic description. For some entities,
an  immunohistochemical profile is also given that should be helpful in proper diagnosis.
As  many pathologic diagnoses nowadays also include genetic studies, the most common
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or posterior cranial fossa. Such an approach is presented in1.  Introduction
Tumors of the skull base are a distinct group and, unlike in
other cases (e.g. organ specific), they are grouped according to
their anatomic location which is used by surgeons. Usually, the
pathologic classification refers to tumors’ origin, such as the
epidermis, bronchial epithelium or soft tissues. Such classifi-
cation roughly introduces two groups of tumors: epithelial and
non-epithelial, according to their origin. In the skull base, one
can find bone, peripheral nerves, large vessels and soft tissues
from which different tumors could arise. Additionally, as there
are plenty of surrounding structures (e.g. the central nervous
system, sinuses, pharynx, etc.), the number of possible tumors
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cific diagnoses, increases. Of course, benign as well as malig-
nant tumors could grow in all of the aforementioned situa-
tions. Moreover, at the skull base, we  may also find metastases.
Taking into consideration all of the above, the pathology of
tumors in this anatomical region becomes a challenging issue.
From the clinical point of view, tumors are most commonly
grouped according to their anatomical occurrence. In the case
of skull base tumors, this allows us to group tumors according
to whether they grow within or around the anterior, middleland Cancer Center, Garbary 15, 61-866 Poznan, Poland.
the majority of clinical descriptions (see Table 1).1–3 However,
specific tumors (e.g. meningioma, neuroma or chordoma)
may develop in all the sites and the morphological picture is
Sp. z o.o. All rights reserved.
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Table 1 – Tumors of skull base and their distribution in relations to anatomic localization (related to anterior, middle and
posteriori cranial fossa).
Anterior Middle Posterior




Tumors invading from adjacent structures Paraganglioma Chordoma
Carcinoma (mainly squamous cell carcinoma from nasal cavity) Glioma
Adenoid cystic carcinoma Teratoma
Lymphoma Squamous cell carcinoma
Plasmocytoma Plasmocytoma
Melanoma malignoma Lymphoma








































imilar in all locations. This review is focused on tumors that
ight develop or invade the skull base region, and where the
tandard classification would be difficult to apply. In the next
ection, selected most common tumors are presented with an
ndication of their most common location.4,5 As this issue of
he journal has a review standard, because of the encyclope-
ic character of the article, the following tumor descriptions
ould be given in alphabetic order, although it would perhaps
e more  appropriate to present lesions according to their his-
ogenesis. As such, the most suitable classification includes
umors grouped as follows: epithelial, soft tissue, tumors of
he bones and cartilage, neuroectodermal and hematopoietic.
.  Tumors  of  epithelial  origin
.1.  Squamous  cell  carcinoma
efinition: A malignant epithelial tumor with squamous cell
ifferentiation.
Epidemiology: Depends on the site of the primary tumors
ear or temporal bone, gnathic bones, larynx, oropharynx,
inonasal tract, salivary glands). Usually occurring in middle
ged or older adults. Currently, together with the increased
ncidence of HPV infection, tumors develop in younger
atients. Metastatic tumors also occur.6,7
Morphologic picture:  Histologically, there are recognized
ubtypes of squamous cell carcinoma such as: squa-
ous keratinized, squamous non-keratinized, basaloid or
denosquamous carcinomas. In all cases, the microscopic
eatures or immunohistochemical profile (expression of cytok-
ratins and p63) should indicate some degree of squamous
ifferentiation. A full morphological diagnosis should include
n examination of HPV infection status, either by direct
mmunostaining for HPV or for p16 (which is activated in HPV-
elated tumors).
Differential diagnosis: The presence of keratin (extracellular
r intracellular) in some squamous cell carcinomas makes
iagnosis easier. In cases with poor differentiation, regardlessof the site of origin of the tumor, especially in those cases
with predominant spindle cells, differentiation between
sarcoma and inflammatory myofibroblastic tumor should be
performed. Usually, the application of a panel of immuno-
histochemical stains using epithelial markers (cytokeratins,
p40, p63) and mesenchymal markers (vimentin, CD34, SMA)
is sufficient for proper diagnosis.8–10
2.2.  Nasopharyngeal  carcinomas
Definition: Carcinoma developing in the nasopharyngeal
mucosa with features of squamous cell differentiation,
according to the WHO  classification.1
Epidemiology: The peak incidence is in the 5th and 6th
decades, with a twofold male predominance. The risk of tumor
development increases with EBV infection.
Morphologic picture:  The tumor is composed of areas
(islands, sheets or trabeculae) of carcinoma (depending of the
subtype, with squamous, basaloid or transitional cell type
appearance), which are admixed with variable amounts of
lymphocytes (Fig. 1a and b).
Other important notes: Other names used include syn-
onyms: lymphoepithelioma, lymphoepithelial carcinoma or
Schmincke type lymphoepithelioma. The same terminology
is used for such entities as: nonkeratinizing carcinoma, kera-
tinizing squamous cell carcinoma and basaloid squamous cell
carcinoma.
Differential diagnosis: This tumor belongs to a group of poorly
differentiated malignancies. The first differentials should be
made with diffuse large B cell lymphoma (some cells might
have an epithelioid appearance, but express B-cell markers),
malignant melanoma (some cases show clearly visible intra-
cytoplasmic pigment and are positive for HMB45, S100 and
melan-A), and rhadomyosarcoma (mainly by use of muscle
differentiation markers including: desmin, MyoD1 or Myf4).
Differentiation with other types of nonkeratinizing carcinoma
is done by confirmation of viral infection: nasopharyngeal
carcinoma is EBV positive, while other carcinomas could be
HPV-related (confirmed by p16 staining).8,11–14
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Fig. 1 – (a) In nasopharyngeal carcinoma, the two
components are mixed. Tumor cells of low maturation
level, as in the presented tissue sample, are
distributed/infiltrating the stroma, which is rich in
lymphocytes. Hematoxylin and eosin staining, primary
objective magnification 20×.  (b) In this example, by means
of immunohistochemical procedures with cytokeratin
markers (CK 5/6), the squamous cell carcinoma component
is made clearly visible against a dense lymphocytic
Fig. 2 – Craniopharyngioma is composed of epithelial cells
which form nests or trabeculae with palisading at the
periphery. Hematoxylin and eosin staining. Primaryinfiltrate. Primary objective magnification 10×.
2.3.  Craniopharyngioma
Definition: A usually benign tumor developing from Rathke’s
pouch/cyst structures.
Epidemiology: Up to 30% of the tumors develop before
puberty.
Morphologic picture:  According to the histologic picture,
three types are recognized: adamantinomatous (so called
“pediatric” as it typically occurs before the age of 14) and papil-
lary (also called “adult type”). A mixed subtype also exists. The
pediatric type is usually poorly circumscribed. The epithelial
cells form nests or trabeculae with palisading at the periph-
ery (Fig. 2). In cystic areas, abundant keratin is noted. In the
adult type, papillary structures are lined by squamous epithe-
lium resembling squamous cell papilloma. In the adult type, in
contrast to the pediatric type, no “wet” keratin, calcifications,
or xanthogranulomatous inflammation is to be found.15,16
Other important notes: Recurrences have been recorded after
incomplete excision. Malignant transformation is related toobjective magnification 10×.
development of squamous cell carcinoma. Involvement of the
skull base might follow the development of a tumor in the
suprasellar area, with penetration down to the bone, or in
very rare cases, primary craniopharyngioma developing in the
nasopharynx.17
Differential diagnosis: As the epithelium of the canal in
cases of craniopharyngioma may show some degree of atypia,
squamous cell carcinoma should be taken into consideration.
Demonstration of p53 should be helpful in such cases, as this
marker is highly expressed in squamous cell carcinoma.6,18,19
2.4.  Cholesteatoma
Definition: A benign tumor composed of keratin-filled cysts
occurring in the middle (more commonly) or external ear.
These tumors may develop as either a congenital malforma-
tion (entrapment of squamous epithelium within bone) or as
an acquired lesion (when injury or retraction of the tympanic
membrane occurs).
Epidemiology: Usually young males.
Morphologic picture:  The tumor may range from a small to
rather large cyst. Microscopically, the cyst is filled with keratin
masses. Around the lesion, chronic inflammatory infiltrate
forms a part of the picture. Granulation tissue as well giant
multinucleated cells of foreign body (keratin or fragment of
destroyed bone) type are also found. In older lesions choles-
terol crystals can be found.20
Other important notes: As tumors of large diameter might
lead to destruction of the bone, a careful differential diagno-
sis with squamous cell carcinoma should be performed. In the
latter entity, cellular atypia and desmoplastic stromal reac-
tions support the diagnosis of a malignant lesion. Some of
such lesions may be HPV positive.
Differential diagnosis: Taking into account the clinical pic-
ture and the presence of cholesterol crystals, the diagnosis
should be straightforward. However, in cases with high cel-
lular atypia and reactive (desmoplastic) changes within the
stroma, a differential diagnosis of squamous cell carcinoma
should be explored. In order to make a diagnosis of squa-
mous cell carcinoma “true” stromal invasion must be found.
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he presence of metastases (typical for carcinoma) makes the
iagnosis much easier.18
.  Salivary  gland  tumors
efinition: This is a very heterogeneous group of tumors, both
enign and malignant (see Table 2 for common entities). A
etailed description of the lesions is presented elsewhere.
.1.  Adenoid  cystic  carcinoma
efinition: The alternative, former, name is cylindroma (based
n the histologic structure). Primary tumors can develop
ithin the salivary glands (usually minor ones) or, less com-
only, in the mucosa of the upper respiratory tract, includinghe nose and sinuses. Primary lesions can also develop in the
kin and, notably, the most common localization is the head
nd neck area. The tumor arises from the glandular structures





















Adenoid cystic carcinoma (Cylindroma)
Polymorphous low-grade adenocarcinoma
Epithelial-myoepithelial carcinoma



















Fig. 3 – (a) A typical low-power view of carcinoma
adenoides cysticum with a partially cribriform and partially
solid pattern. Pseudoglandular structures are easily
recognized. Hematoxylin and eosin staining, primary
objective magnification 4×. (b) On microscopic examination
of carcinoma adenoides cysticum, a peculiar tendency for
nerve invasion is usually found. Hematoxylin and eosin
staining, primary objective magnification 20×.
of the salivary glands and from the apocrine glands of the skin.
Previously, it was associated with eccrine differentiation.5,18
Epidemiology: The tumor is most common in mature adults,
incidence peaks between the 5th and 6th decades. There is a
slight male predominance.
Morphologic picture:  Macroscopically, the tumors range from
around one to more  than 8 cm and have poorly defined bor-
ders. Microscopically, there are recognized variants: solid,
cribriform and tubular (Fig. 3a and b). Some authors also
include a mixed pattern. Regardless of the variant, the tumor
is composed of small uniform cells with dark nuclei and scant
cytoplasm. Usually, there are visible pseudoglandular spaces
filled by PAS positive material and with the appearance of
basement material in transmission electron microscopy stud-
ies. Sometimes, there are true glandular lumina containing
mucin. One of the hallmarks of this tumor is its peculiar
tendency for perineural invasion, which was, until recently,
considered pathognomonic for its diagnosis. However, other
tumors with perineural invasion have now been recognized.
The immunohistochemical profile of adenoid cystic carci-
noma is as follows: CK7+, CK20 negative, CD117+ (usually cells
d radiotherapy 2 1 ( 2 0 1 6 ) 288–303
Fig. 5 – Lipomas are characterized by the presence of
mature adipocytes. As it is a soft tissue tumor, cells
differentiating into benign fibroblasts can also be seen.
Hematoxylin and eosin staining, primary objective
magnification 10×.292  reports of practical oncology an
in ducts), S100+, alpha-1-antichymotrypsin+ (usually cells in
ducts).
Other important notes: Regardless of the rather indolent
microscopic picture, the tumor can recur, even after several
years, and seldom gives lymph node metastases. The best
prognosis is for the tubular variant with an expected survival
of almost 40% after 15 years.
Differential diagnosis: The diagnosis of primary salivary
gland adenoid cystic carcinoma should be made after exclu-
sion of metastases from its skin related counterpart. Other
differentials include salivary gland low-grade polymorphous
adenocarcinoma, basal cell adenocarcinoma or basal cell
adenoma. In the majority of cases, examination of multi-
ple samples from a tumor should be enough to make a
proper tumor discrimination. I in some cases the immuno-
profile, especially the CGFP and CD117 status, could be helpful.
Worthy of note is the issue of neural invasion, which was pre-
viously regarded as being exclusively found in adenoid cystic
carcinoma, but now described by many  authors in other sali-
vary gland tumors.18,20–22
4.  Soft  tissue,  bone,  and  cartilage  tumors
4.1.  Hemangioma
Definition: A benign tumor derived from the endothelium of
blood vessels.
Epidemiology: Occur at any age, but occurrence during child-
hood and in adolescent males is most common.
Morphologic picture:  The tumor is composed of vascular
channels lined by endothelial cells. According to the size of the
vessels, two types are recognized: capillary (showing channels
with a small luminal diameter) (Fig. 4) and cavernous (when
large, dilated vascular spaces are observed). Such tumors may
be lobulated. The endothelial cells are benign looking, and
mitoses are common, but never atypical. The immunohis-
tochemical profile includes reactivity with CD31, CD34 and
factor VIII (von Willebrandt factor).
Fig. 4 – In this case of hemangioma, multiple small blood
vessels are clearly visible. The newly  formed capillaries are
lined by cuboidal endothelial cells. Hematoxylin and eosin
staining, primary objective magnification 20×.Other important notes: As the morphology overlaps with
other entities, the differential diagnosis includes: granulation
tissue, vascular malformations and teleangiectasias.
Differential diagnosis: The microscopic features are rather
unique; however, in some cases they could be differenti-
ated from lymphangioma using podoplanin (antibody D2-40)
against endothelial cells of the lymphatics.2,18
4.2.  Lipoma
Definition: A benign soft tissue tumor composed of mature fat.
Several subtypes are recognized according to the stage of dif-
ferentiation, from stem cells to mature adipocytes.
Epidemiology: Lipoma occurs most commonly between 40
and 60 years of age.
Morphologic picture:  Macroscopically, benign tumors are well
circumscribed and encapsulated. According to the fat content,
they are yellow, gray-white or pale-pink and are sometimes
myxoid. On microscopic examination, well-differentiated
mature adipocytes are found. In other cases fibroblast-like
spindle cells can be found (Fig. 5). By definition, lipoblasts
are not found in benign cases. The presence of lipoblasts is
an indication of malignancy and the appropriate diagnosis is
liposarcoma.
Other important notes: Some lipomas carry the translocation
t (12q, 13–15).
Differential diagnosis: In benign tumors the diagnosis is
easy, based on the presence of well-developed and mature
adipocytes. In cases of poorly differentiated liposarcomas, the
differential diagnosis includes all other poorly differentiated
mesenchymal tumors such as fibrosarcoma, leiomyosarcoma,
rhadomyosarcoma and malignant peripheral nerve sheath
tumor, as they might present a similar histologic pattern.
For liposarcoma the key diagnostic feature is the presence
of lipoblasts together with MDM2 and CKD4 positivity on
immunostaining.18,23,24

















































Fig. 6 – (a) Chondrosarcomas are composed of cells with
varying levels of differentiation toward chondrocytes. For
diagnostic purposes, chondroid matrix production is an
important feature. Hematoxylin and eosin staining,
primary objective magnification 10×.  (b)
Immuhistochemical evaluation of the expression of the
proliferation marker, Ki-67. In this case, focally, up to 10%
of cells are positive (meaning that 10% of cells are in a cell
cycle phase other than G0). Primary objective magnificationreports of practical oncology and 
.3.  Chondroma
efinition: A benign tumor of mesenchymal origin with differ-
ntiation toward cartilage.
Epidemiology: Benign (primary) chondromas in skull bases
re extremely rare entities.
Morphologic picture:  Benign-looking chondrocytes arranged
n nests and surrounded by connective tissue.
Other important notes: There have been case reports of mul-
iple chondromas in the skull base area, developing from
yndromes of chondromatosis.
Differential diagnosis: In some cases, differential diagnosis
ith low-grade chondrosarcoma can be difficult. Correlation
ith radiologic features should be helpful.
.4.  Chondrosarcoma
efinition: Malignant soft tissue tumor, which is the third most
ommon primary bone tumor (after osteosarcoma and plas-
ocytoma). Primary tumors in the head and neck area are
are, although they represent around 10% of all cases of chon-
rosarcoma. Such tumors may develop from the skull base,
he nasal septum, or the gnathic bones.
Epidemiology: There are two peaks of incidence. The first of
hese occurs in young adults, around the 2nd or 3rd decade
this is the so-called mesenchymal type), while the other one
ccurs after 40 years of age.
Morphologic picture:  Macroscopically, tumors are light blue to
early-white and translucent. A lobular configuration occurs
n low-grade tumors. In high-grade tumors, areas of necrosis
nd hemorrhage are usually visible. Microscopically, as a main
omponent of the tumor formation, hyaline cartilage is seen.
ytologically, the tumor cells range from rather uniform round
hondrocytes to spindle or clear cells, or dedifferentiated vari-
nts. There can be variable production of extracellular matrix,
ncluding cases with an extensive myxoid component (Fig. 6a
nd b). There may also be visible bone destruction, locally.1,20
Other important notes: There are reports of primary chon-
rosarcomas developing as primary lesions of the larynx or as
 component of salivary carcinomas. The benign counterpart,
amely chondroma, is very rare in the head and neck area.
Differential diagnosis: Differential diagnosis with other
igh-grade mesenchymal tumors such as osteosarcoma,
brosarcoma, rhabdomyosarcoma, and liposarcoma should be
onsidered in the case of dedifferentiated tumors. In such
ases, morphologic features should be combined with the
esults of immunohistochemical studies. For differentiation
ith osteosarcoma, the presence of bone formation by neo-
lastic cells of the latter tumor is a crucial feature, but might
equire the review of multiple tumor samples. Differentia-
ion with rhabdomyosarcoma can be based on the presence
f desmin, myoD1 or Myf4 antigens that are consistent with
uscle differentiation. This can be done by immunohisto-
hemistry. Fibrosarcoma, in contrast to chondrosarcoma, is
-100 negative and, in histochemical stains, presents a reti-
ulin positive rim around each cell. Poorly differentiated
hondrosarcoma could be discriminated from liposarcoma by
he presence of MDM2  and/or CDK4, which are typical for the
atter.25,2620×.
4.5.  Rhabdomyosarcoma
Definition: A malignant tumor of the so-called soft tissues (of
mesenchymal origin), with skeletal muscle differentiation.
Epidemiology: In the nasopharyngeal localization, these
tumors usually develop before the age of 20, with male pre-
dominance.
Morphologic picture:  The tumor masses may have ade-
structive impact on surrounding structures. Microscopic
examination allows the differentiation of three variants,
namely: embryonal, alveolar and pleomorphic (that do not
usually occur in the head and neck area). Regardless of sub-
type, the key diagnostic feature is an indication of skeletal
muscle differentiation. It can be done by identification of mus-
cle striatations (by either light or electron microscopy; in the
latter, the presence of thin and thick filaments may be used
as a minimal diagnostic criterion) or by immunohistochem-
istry; by confirmation of the expression of desmin, myoglobin,
294  reports of practical oncology and rad
Fig. 7 – (a) In this case of rhabdomyosarcoma,
differentiation toward skeletal muscle is visible in a part of
the tumor. There is also a great variety of tumor cell
shapes. Hematoxylin and eosin staining, primary objective
magnification 20×.  (b and C) Muscle differentiation was
confirmed by immunohistochemistry tests for the presence
of desmin (micrograph b) and the Myf4 marker (micrograph
c). In both micrographs, primary objective magnification
discohesive cellular infiltrate in a patternless array is found,20×.
myogenin, MyoD1, Myf3, Myf4 and SMA. In the embryonal sub-
type, the tumor cells may be round to spindle shaped, with a
primitive mesenchymal appearance (Fig. 7a–c). The cell nuclei
are hyperchromatic. In the alveolar subtype, typically loosely
cohesive primitive rhabdomyoblasts are surrounded by fibrous
septa.iotherapy 2 1 ( 2 0 1 6 ) 288–303
Other important notes: In some centers, for diagnostic pur-
poses, the presence of the FKHR gene mutation and fusion
with PAX3 or PAX7 is used for confirmation of alveolar
rhabdomyosarcoma.1,18,20
Differential diagnosis: As the cell of origin is the rhabdomy-
oblast, a diagnostic feature is the presence of cross-striations,
but these are rarely visible at the histologic level (it is much
easier to see them on ultrastructural studies). Some cases
present as polypoid masses protruding from ear, and they
should differentiated from aural polyps. In rhabdomyosar-
coma of the botryoid subtype (itself a subtype of embryonal
rhabdomyosarcoma), lying beneath the epithelium, there is a
cambium layer with rhabdomyoblasts whose presence may
be confirmed by the aforementioned immunohistochemistry
tests. As rhabdomyosarcoma belongs to the group of so-called
small blue cell tumors, it should be differentiated from lym-
phoma (atypical lymphocytes can be identified by T or B cell
markers), melanoma (which should react with some of the
following markers: S100, melanosome, melan-A) and from the
Ewing sarcoma family of tumors (these lack myogenic markers
but show strong cell membrane immunoreactivity for CD99,
Fli-1).6,18,27
5.  Central  peripheral  nervous  systems
originating  tumors
5.1.  Tumors  of  neuroepithelial  origin
Such tumors are normally within the scope of neuropathology,
but sometimes invade the skull base. In the following section
selected tumors will be briefly introduced.11,28,29
5.2.  Glial  tumors
Definition: A group of tumors of glial differentiation. Recog-
nized are such entities as: astrocytic neoplasms (including the
most malignant glioblastoma), ependymomas, and oligoden-
drogliomas.
Epidemiology: As this is a complex group some details will be
presented in the following section while morphologic variants
will be displayed.
Morphologic picture:  According to the present classification,
the largest group consists of diffusely infiltrating astrocy-
tomas. This group, according the cytologic appearance, can be
further divided into fibrillary, gemistocytic and protoplasmic
variants. The most common primary neoplasm of the brain
is fibrillary astrocytoma with the main localization in white
mater of hemispheres (in adults). Other sites observed include,
in decreasing order of incidence, cerebellum, brain stem, and
spinal cord. They are most frequently diagnosed in the 4th to
6th decades of life.
Macroscopically, these tumors present with diffuse expan-
sion and blurring or effacement of gray-white matter. Usually,
neither hemorrhage nor necrosis is found. Microscopically, awith only slight hyperchromasia of the nuclei. Nuclei are typ-
ically round or oval and with a vesicular quality. There are no
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There are also other types of astrocytomas, such as proto-
lasmic astrocytoma (occurring more  commonly in the gray
atter), pilocytic juvenile astrocytoma (so named as they
re typically present in childhood, adolescence or early adult
ife; with a predilection for the cerebellum and the third
entricle region, they have a typically biphasic cellular presen-
ation, namely fascicular and microcystic array), pleomorphic
anthoastrocytoma (alarming as it looks, using only histo-
ogical criteria, it is a relatively indolent tumor; typically
resent in adolescence and in early adult life. It is a well-
emarcated tumor, most commonly located in the temporal
obes), subependymal giant cell astrocytoma (typically in the
st or 2nd decade of life, and is associated with tuberous
clerosis – Bourneville’s disease), and desmoplastic cerebral
strocytoma of infancy (which grows in the first year of life,
anifesting with increased intracranial pressure). Also diag-
osed are mixed gliomas, which present elements suggesting
ifferentiation along more  than one of the cell lines described
bove.28,30
In anaplastic astrocytoma (female predominance, peak
ncidence in 5th decade), grade III according to WHO  four-
rade malignancy classification and which in most cases
volves from well-differentiated precursors, typical micro-
copic findings include: nuclear angulation, variations in
ontour and dimension, and dense hyperchromasia. In con-
rast to the entities above, mitotic figures and increased
ascular blood supply are observed.
The most malignant entity in this group is glioblastoma,
lso called glioblastoma multiforme (WHO grade IV) which
ay develop as a “primary” or as a “secondary” tumor. The
ormer occurs de novo, which means that there was no
emonstrable precursor lesion. The latter is attributed to cases
howing malignant transformation of a benign lesion. Epi-
emiological studies indicate that this tumor accounts for
bout 10–15% of brain tumors of adults.
Macroscopically, these tumors are presented as relatively
ell circumscribed (a peculiar feature of central nervous
ystem malignancies; in other localizations, the majority
f malignant tumors have poorly defined borders). Hemor-
hagic and necrotic areas are very common. Histologically,
t is a highly cellular and pleomorphic tumor with extreme
ariation in cytologic features. There are well-differentiated
lements/cells which can be intermingled with bizarre mul-
inucleated giant, spindle, epithelioid, rhabdoid, small or
ignet-ring tumor cells. Mitoses are numerous. Proliferat-
ng blood vessels (used by some pathologists as a hallmark
f the tumor) may be present as glomeruloid or solid
ufts.18,28
Oligodendrogliomas constitute about 5–15% of gliomas.
hey are most common in the 4th–5th decade of life and
evelop mainly within white matter of the hemispheres
frontotemporal or parietal lobes location). Macroscopically,
hey are well-demarcated masses of soft, grayish-pink tissue,
sually in the subcortical white matter. Cystic changes are
ommon. In the classic presentation, microscopic examina-
ion shows a sheet-like or permeative proliferation of uniform,
ound nuclei surrounded by optically clear halos. Perineu-
onal aggregation (satellitosis) is seen. When mitotic activity is
resent and foci of coagulative necrosis and dense cellularity
re found, they are features of anaplastic oligodendroglioma.therapy 2 1 ( 2 0 1 6 ) 288–303 295
Ependymomas are the least common (4–6% of all CNS pri-
mary  tumors) in this group. In children, they usually occur as
intracranial tumors, and as intramedullary lesions in adults.
About 75% of lesions in children are infratentorial (IV ventri-
cle) and cause increased intracranial pressure secondary to
obstructive hydrocephalus. Macroscopically, they have grayish
or white coloration and a granular texture, friable consis-
tency, lobulated contours and remarkable circumscription
(being better demarcated than astrocytomas). On microscopic
examination, the most common form is the cellular vari-
ant. In this tumor perivascular pseudorosettes and dystrophic
calcifications are found (sometimes with osseous or chon-
droid metaplasia). The anaplastic (malignant) ependymoma
is characterized by cellular density, mitoses, increased pleo-
morphism with vascular proliferation, and the presence of
necrosis.
Other important notes: For fibrillary astrocytoma, risk fac-
tors include: irradiation, type 1 neurofibromatosis, Turcot’s
syndrome (colonic polyposis), and HIV-1 infections. As some
authors suggest tumor biology depends in part on p53 and
retinoblastoma gene expression.1,28
Differential diagnosis: The glial origin of cells could be
confirmed by the presence of GFAP immunoreactivity (with
differing proportions of positive cells depending on the spe-
cific subtype). Subsequently, diffuse fibrillary astrocytoma
could be differentiated from gliosis (a reactive change) by
the presence of hypertrophy, but not hyperplasia, of glial
cells in the latter lesion. Glioblastoma could be differenti-
ated with lymphoma or metastatic carcinoma through the
presence of small cells, but in all histologically questionable
cases, immunostaining for GFAP and hematopoietic markers
or cytokeratins should be helpful. Some cases of ependy-
moma  could mimic  glioma, but the former is characterized
by the presence of true rosette formation by neoplastic cells
as well as by intracytoplasmic microvilli lined lumina (visi-
ble at the ultrastructural level). Oligodendrogliomas that show
clear cells should not be confused with clear cell meningiomas
or with clear cell ependymoma or metastatic clear cell carci-
noma. In such cases as these, additional immunostaining is
crucial.20,28
5.3.  Esthesioneuroblastoma
Definition: In the WHO  classification, this neoplasm is currently
named as olfactory neuroblastoma. It is a malignant tumor
derived from the olfactory membrane of the sinonasal cav-
ity. It is a rare and malignant tumor occurring only in this
localization.
Epidemiology: It might occur from childhood to late adult-
hood with peak prevalence around 50 years of age.
Morphologic picture:  Macroscopically, these usually form
large, highly vascularized, polypoid structures. The lesion
usually develops in the submucosa and is covered by nor-
mal  mucosa. The size varies from small to large lesions
with invasion of the paranasal sinuses and orbit. On micro-
scopic examination, nests or lobules of uniform small cells
are present, with inconspicuous nucleoli in “salt and pepper”
nuclei, without pleomorphism. Groups of cells are separated
by fibrous stroma. The cytoplasm of such cells is usually
scanty. Necrosis is usually absent. As it has a neural origin, one
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Fig. 8 – Whorls of meningothelial cells are present. In this
micrograph the tumor cells are highlighted by
immunohistochemical staining for vimentin. Primary
objective magnification 20×.296  reports of practical oncology an
third of cases also show Homer-Wright pseudorosettes as well
as Flexner–Wintersteiner rosettes. In immunohistochemical
studies, consistent expression of NSE is seen, together with
synaptophysin and neurofilament positivity in the majority
of cases. Positivity for GFAP and chromogranin has also been
reported. S-100 is positive only in sustentacular cells that form
a thin rim around the tumor cell lobules. Markers such as EMA,
cytokeratins, CEA, CD99 and HMB45 are absent in the case of
esthesioneuroblastoma.31,32
Other important notes: The name is not associated with neu-
roblastomas occurring in other localizations.
Differential diagnosis: As the tumor is composed of small
round “blue” cells, it should be differentiated from other
lesions with the same microscopic appearance. Such tumors
may include lymphoma, rhabdomyosarcoma, malignant
melanoma, neuroendocrine carcinoma or sinonasal undiffer-
entiated carcinoma. In almost all cases the proper diagnosis
should be made after immunohistochemistry. Lymphoma
may be excluded after stains for leukocyte antigens while
malignant melanoma is positive for HMB-45 and/or melan-
A. In the case of rhadomyosarcoma, muscle differentiation
markers (myoD1, Myf4, desmin) are key elements, while in
the case of carcinomas, both neuroendocrine and undif-
ferentiated, at least some of the cytokeratins should be
demonstrable.33
5.4.  Choroid  plexus  papilloma
Definition: A benign tumor that recapitulates the structure of
choroid plexus.
Epidemiology: Almost all occur in children below 10 years of
age.
Morphologic picture:  Macroscopically, the tumor is lobulated.
Microscopically, it resembles normal choroid plexus. It is usu-
ally composed of one layer of epithelial cells which may be
pigmented, oncocytic, osteogenic or mucus-secreting, with
mild atypia, and overlying a fibrovascular core.
Other important notes: All choroid plexus tumors are very
rare. They constitute below 0.5% of all intracranial tumors. Up
to 30% of these tumors might undergo malignant transforma-
tion. Some examples of this tumor are found in Li-Fraumeni
syndrome and Aicardi syndrome.
Differential diagnosis: Some tumors might resemble ependy-
moma  (myxopapillary subtype) but such tumors occur in
different locations. Yet another differential diagnosis is pap-
illary meningioma, but typical cell whorls of meningothelial
cells can be recognized in such tumors during a detailed
microscopic examination.20,28
5.5.  Meningioma
Definition: A benign tumor composed of meningothelial cells.
Epidemiology: Meningioma belongs to one of the most com-
mon  primary intracranial lesions. It occurs most commonly
in mid  adult life. Women are much more  commonly affected
(especially those with breast tumors), which is attributed to
the presence of receptors for progesterone.
Morphologic picture:  Macroscopically, it is a solid lobulated
mass, broadly anchored to the dura matter. In some cases
this tumor may permeate the neighboring skull structures,provoking a highly characteristic form of osteoplastic expan-
sion (hyperostosis). On cross-section, meningiomas are
usually grayish-tan and soft (but highly collagenized exam-
ples are also found). Calcification is rarely apparent on
gross examination. Microscopically, so-called meningothelial
cells are observed, with delicate round or oval nucleoli and
inconspicuous nucleoli. The cytoplasm is lightly eosinophilic
and cytoplasmic borders are indistinct. Commonly, tumor
cells are concentrically wrapped in tight whorls (Fig. 8), with
pale nuclear “pseudo-inclusions” consisting of invaginated
cytoplasm. Lamellated calcospherules, known as psammoma
bodies, are also found. According to the WHO  classification,
meningiomas are graded from 1 to 3. The grade 1 group
consists of nine subtypes (menigothelial, fibrous/fibroblastic,
transitional/mixed, psammomatous, angiomatous, micro-
cystic, secretory, lymphoplasmocytic and metaplastic), three
subtypes fall into the grade 2 category (chordoid, clear cell
and atypical) and further three subtypes are in grade 3
(papillary, rhabdoid and anaplastic). Arachnoid cap cells
(so called meningothelial cells) have been identified as the
origin of menigiomas. In immunohistochemical studies
they were found to be positive for EMA, CK18, CEA, claudin
1 (in up to 50% of cases) and negative for CK20, vimentin
(in some cases), S-100 (except in fibrous meningioma)
and GFAP.11,34
Other important notes: Multifocal meningiomas are typi-
cally found in cases of type 2 neurofibromatosis. Other risk
factors include ionizing irradiation and trauma. Most menin-
giomas develop within the cranial cavity and are dura mater
based, being found in the vicinity of the superior sagittal
sinus.
Differential diagnosis: In cases with predominant spindle
cells, the main differentials include: schwannoma, heman-
giopericytoma and solitary fibrous tumors, all of which are
negative for claudin-1. Additional staining could be helpful,
S100, for example, is positive in schwannomas, CD34 is pos-
itive in solitary fibrous tumors and in hemangiopericytomas.
Some of the above markers may be positive in specific sub-
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.6.  Neurilemmoma
efinition: A benign tumor composed of differentiated neoplas-
ic Schwann cells (also called Schwannoma).
Epidemiology: This is the most common tumor of the periph-
ral nerve, comprising about 8% of all intracranial tumors
with 80–90% of the cerebellopontine angle). Peak incidence is
n the 3rd through 6th decades of life. For those arising within
he skull, there is a predilection for the sensory nerves (espe-
ially for nerve VIII). Those arising in extradural locations have
 predilection for the mixed motor and sensory nerves.
Morphologic picture:  The majority of these tumors are
olitary and discrete. Macroscopically, these are firm, encap-
ulated, tan and translucent, often yellow (in cases with
anthomatous degeneration) or red in color (when hemor-
hage develops). They grow centrifugally with compression of
he surrounding tissues but without infiltration. Microscopi-
ally, they are comprised of uniform cells of the Schwann cell
henotype, which are spindle shaped, with pale cytoplasm
hat merges with adjacent collagen bundles. The nuclei are
longated. In some cases the cells may be aligned parallel to
he interwoven fascicles. A compact configuration known as
ntoni A, together with an areolar or myxomatous appear-
nce, known as Antoni B (Fig. 9) may also form. The palisading
umor cells’ nuclei, arranged in a pattern resembling piles
n a fence with an intermediary anuclear zone, constitute
he hallmark known as Verocay bodies. Areas of degen-
ration, even with cellular pleomorphism, are sometimes
ound in older lesions. In some cases a few mitoses may be
bserved.
Other important notes: This tumor is sometimes named
chwannoma. In type 2 neurofibromatosis (in which a muta-
ion on the NF2 gene of chromosome 22q causes the
roduction of a gene product called: schwannomin) lesions
an be bilateral with multiple meningiomas.
Differential diagnosis: As the tumor is composed of spin-
le cells, sometimes in fascicles, it should be differentiated
rom fibromas, which are S100 negative and CD34 positive,
nd from meningiomas, which are S100 positive but also
ig. 9 – Elongated cells, singly interwoven or arranged in
ascicles, are distributed within a partially myxomatous
troma. In this micrograph, the Antoni B subtype is
resented. Hematoxylin and eosin staining, primary
bjective magnification 10×.therapy 2 1 ( 2 0 1 6 ) 288–303 297
EMA positive. The latter entity is also composed of menig-
othelial cells, which have a characteristic appearance. The
differentiation with neurofibroma is of some interest, as both
neurilemmoma and neurofibroma are S100 positive. CD34
positivity is stronger, however, in a fibroblastic admixture of
the former tumor. Differentiation with malignant peripheral
sheath tumors is mainly based on the degree of cellular pleo-
morphism, the presence of necrosis and a high mitotic rate.
The infiltrative growth pattern is also typical for a malignant
tumor.1,20
5.7.  Paraganglioma
Definition: A tumor developed from the paraganglia outside the
adrenals. They develop along the structures of the paraverte-
bral sympathetic and parasympathetic chains.
Epidemiology: These are rare tumors, occurring mainly in
the 5th and 6th decade, with a twofold female predominance.
Morphologic picture:  Tumors range from small up to more
than 10 cm in diameter. Macroscopically, they are well circum-
scribed and encapsulated by fibrous tissue. Microscopically,
the most characteristic features are zellballen, arrangements
of variously sized nests of tumor cells (Fig. 10a and b) sur-
rounded by fibrotic septa. The main types of cells vary in
appearance, from those with finely-granular cytoplasm to
deeply basophilic ones. There are cases with clear cells as
well. The nuclei are also rather pleomorphic with some being
small and round while others are large or even vesicular. The
second cell type present, which is typically S100 positive, are
sustentacular cells that surround the aforementioned nests of
cells.
Other important notes: The immunohistochemical profile of
these tumors reflects their neuroendocrine origin, with pos-
itive reactions for chromogranin, synaptophysin, CD56, NSE,
leu7, S100 and even somatostatin or calcitonin.
Differential diagnosis: In cases without the zellbalen pat-
tern, paragangliomas usually require differentiation from
neurilemmoma/schwannoma (which are S100 positive whilst
being synaptophysin and chromogranin negative) and menin-
gioma which is EMA positive but negative for neurosecretory
markers.18,35,36
6.  Hematopoietic  tumors
6.1.  Lymphomas  (from  mucosa  of  the  nose,  sinuses)
Definition: Mucosa-associated lymphoid tissue tumors, most
commonly occur in the nasal cavity and sinuses. The most
common entities in this localization include lymphomas of
NK/T cells, diffuse large B cells, peripheral T cells, or mantle
cells.
Epidemiology: Tumors of the nasal cavity and paranasal
sinuses lymphomas, as a group, are the second most common
primary malignancy of the skull base. Extranodal NK-/T-cell
lymphoma of the nasal type occurs more  commonly in Asia
and South America and is rare in the Western world. Its peak
incidence is in the 6th decade with male predominance. The
most common B-cell lymphoma, namely diffuse B-cell lym-
phoma (DLBCL), occurs in the tonsils (70% of cases, and with
298  reports of practical oncology and rad
Fig. 10 – (a) Palish cells of paraganglioma, with polygonal
cytoplasm contours, are gathered in small groups.
Hematoxylin and eosin staining, primary objective
magnification 10×.  (b) On close microscopic view, the
characteristic appearance of zellballen is clearly visible. The
cell nests are surrounded by a thin rim of so-called
sustentacular cells. Hematoxylin and eosin staining,
primary objective magnification 20×.
ACTH), together with the ability to assess their levels in the
peripheral blood, have allowed a new approach to the divisiondecreasing incidence in the nasopharynx and base of tongue)
in patients in their 6th through 8th decade of live with male
predominance.
Morphologic picture: As this is a broad group of tumors,
specific descriptions of these entities have been presented
elsewhere.
Other important notes: It is worth remembering that, for
proper diagnosis of primary lymphomas in this localization,
clinical data combined with laboratory results and patho-
logic studies are required. For this diagnosis a large panel
of immunohistochemical tests (for the evaluation of CD and
other markers) is obligatory. A full description of lymphoma
diagnosis is beyond the scope of this paper and details can be
found elsewhere.
Differential diagnosis: Usually includes other small round cell
tumors such as poorly differentiated carcinoma, malignant
melanoma, or mesenchymal tumors, such as rhadomyosar-
coma. Features typical of the aforementioned entities have
been already presented above.1,37iotherapy 2 1 ( 2 0 1 6 ) 288–303
6.2.  Plasmocytoma
Definition: A tumor of hematopoietic origin, characterized by
the monoclonal growth of plasma cells.
Epidemiology: The pharynx belongs to one of the most com-
mon  localizations for primary plasmocytomas outside the
bone marrow. The peak incidence is around 60 years of age.
Morphologic picture:  The tumor is usually a lobulated mass
of an infiltrative nature. The tumor is normally composed of
a monotonous population of normal or almost normal look-
ing plasma cells (Fig. 11a–c). For the proper diagnosis, the use
of immunohistochemistry is required to reveal restriction of
light chain production (kappa or lambda). Other commonly
used markers include CD138 or CD38 (markers of plasma dif-
ferentiation). Interestingly, as with normal plasma cells, they
are negative for the B cell/lymphocyte marker CD20, despite
being derived from B cells.
Other important notes: Extramedullary plasmocytomas
account for only about 10% of cases with solitary lesions. Thus,
whenever a diagnosis is made, the presence of other such
lesions following the course of multiple myeloma in other
localizations, such as in intramedullary bone, should be care-
fully excluded.
Differential diagnosis: The obvious plasma cell or plasmo-
cytoid appearance includes cells with an eccentrically placed
nucleus, and Dutcher bodies (accumulation of abnormal
immunoglobulins) in the cytoplasm. However, immunohisto-
chemical confirmation of the expression of CD38 or CD138,
with restriction to one of the light immunoglobulin chains,
kappa or lambda, is crucial for diagnosis.20,38,39
7.  Miscellaneous  or  composed  origin
tumors
7.1.  Tumors  of  the  pituitary  gland
From the clinical point of view, these tumors are worthy  of
note because of the possible excess production of hormones
and because of headaches and problems with vision as a result
of the tumor mass compressing the surrounding structures.
A functional approach to the pituitary gland divides it into
the anterior and posterior pituitary. In the former, responsible
for hormone production, we might encounter the develop-
ment of adenoma, carcinoma or oncocytoma. In the latter,
as it is formed by evagination of the central nervous sys-
tem, such tumors as gangliocytoma or astrocytoma might be
anticipated. Epidemiologically, anterior pituitary tumors are
more common, and the following descriptions will focus on
some examples. One of the first classifications was based
on the histological criterion of staining patterns of the aci-
dophilic, basophilic and chromophobic cells from which the
lesion was built. However, as there was no correlation with
the clinical course, it is now of historical value only. Intro-
duction of methods for the evaluation of cell content (such
as immunohistochemistry for prolactin, growth hormone andof these tumors into hormonally active (vast majority) or inac-
tive. However, morphology is almost uncorrelated with the
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Fig. 11 – (a) In this case of hard palate plasmocytoma, a
dense cellular infiltrate of monomorphic cells of
plasmocytoid appearance is visible. Hematoxylin and eosin
staining, primary objective magnification 10×.  (b and c) By
immunohistochemical studies, light chain production
restriction was confirmed. In micrograph (b) positive
cytoplasmic expression of kappa light chains in the tumor
cells can be seen. In micrograph (c) no expression of







icrographs, primary objective magnification 40×.
iology and clinical presentation of these tumors, except that
arger tumors, greater than 1.0 cm,  the so-called macroade-
omas, have a greater tendency for infiltrative growth and
ecurrence. The following is a brief description of some of
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The most common tumor of the anterior pituitary is pro-
lactinoma (or PRL-secreting tumor).28,35,40
Definition: A tumor developing in the pituitary gland and
composed of prolactin producing cells.
Epidemiology: Prolactinoma is the most common primary
pituitary lesion, accounting for about half of all pituitary ade-
nomas and about 80% of functioning cases. It usually develops
between the 3rd and 5th decade of life.
Morphologic picture:  Macroscopically, these tumors form
soft, well-circumscribed nodules that may extend beyond
the sella turcica. About one-third show infiltrative growth,
which may be regarded as a feature of malignancy. His-
tologically, the majority of these tumors are composed of
monomorphic cells, typically of the chromophobic or aci-
dophilic types, with uniform round nuclei, in which delicate,
stippled chromatin may be observed. The nucleoli are incon-
spicuous. The cytoplasm is of moderate quantity. In one fifth
of cases, microcalcifications or small hyaline bodies can be
found.
7.2.  Growth  hormone  secreting  adenoma
Definition: A tumor developing in the pituitary gland, which is
composed of growth hormone producing cells.
Epidemiology: These tumors comprise about one-fifth of
primary pituitary adenomas. Clinical presentation depends
on the age of hormonal tumor activity. Gigantism develops
in cases where the tumor develops before epiphyseal clo-
sure of the long bones (children and adolescent patients).
In adult patients, usually in their forties, acromegaly
develops.
Morphologic picture:  In the majority of cases the cells
are acidophilic or chromophobic with granular cytoplasm.
Nuclei with prominent nucleoli are typical. In this group of
tumors, slight nuclear pleomorphism, as well some mult-
inucleate cells are found. Fibrous bodies are a peculiar
marker of this tumor and are formed by the accu-
mulation or aggregation of intermediate filaments that
react positively with cytokeratins when immunostaining is
performed.
7.3.  Adenoma  secreting  ACTH
Definition: A tumor developing in the pituitary gland, which is
formed by the overgrowth of ACTH producing cells.
Epidemiology: Usually develops during the 4th decade of
life. These tumors are 8 times more  common in females than
males. Cushing’s syndrome is the classical clinical presenta-
tion.
Morphologic picture:  This tumor type is usually composed of
basophilic cells with very granular cytoplasm. In some cases,
hyaline material may be seen surrounding cells, resulting in a
“target-cell” appearance. Papillary cellular formations are also
visible.
7.4.  Null-cell  adenomaDefinition: A tumor developing in the pituitary gland which
shows neither clinical nor immunohistochemical evidence of
hormone production.
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Fig. 12 – (a) Malignant melanomas are typically composed
of polygonal cells with high mitotic rates. Multiple mitoses
are clearly visible. Hematoxylin and eosin staining,
primary objective magnification 40×.  (b)
Immunohistochemical evaluation of S100 expression, the
most consistent marker of melanoma. The tumor cells
present strong expression. Primary objective magnification
20×.  (c) Immunohistochemical expression of melan-A, a300  reports of practical oncology an
Epidemiology: Usually develop in elderly patients.
Morphologic picture:  In the majority of cases, tumors
measure over 1.0 cm in diameter (macroadenoma). The histo-
logical picture most commonly presents chromophobic cells
arranged in diffuse patterns.2,15,35
7.5.  Pituitary  carcinoma
Definition: A tumor developing in the pituitary gland, usually
with hormonal activity, that produces systemic or cran-
iospinal metastases.
Epidemiology: These tumors could occur at any age but
typically in the 3rd–5th decade. There is an equal gender
predilection.
Morphologic picture:  No typical features of malignancy have
been described. High expression of p53 has been found in
immunohistochemical studies.
Differential diagnosis: As the histology of pituitary tumors
has a minor impact on the diagnosis, differentiation between
entities is based on the clinical course and on the hor-
mone production status (either by laboratory tests or by
immunohistochemistry).41
7.6.  Malignant  melanoma
Definition: A malignant tumor derived from melanocytic cells
or their precursors. Primary tumors in the skull base, apart
from those arising in the skin, usually develop in the mucosal
membranes.
Epidemiology: Tumors usually develop in adults and primary
sites are most commonly found in the oral or nasal cavities.
Morphologic picture:  The tumor is composed of atypical
melanocytes. Most commonly, there are sheets or islands of
epitheliod melanocytes (Fig. 12a–c). The cells may be round,
spindle shaped or polygonal, with a high mitotic rate.
Other important notes: The immunoprofile of melanocytes
includes positive reactions to S100 (the most consistent
marker of melanocytes, but least specific), HMB45, and melan-
A.
Differential diagnosis: In the majority of cases, after a
detailed microscopic search, melanin pigment can be found,
its presence being regarded as diagnostic. However, clear cell
melanoma should be differentiated from liposarcoma. For the
former, expression of S100 and HMB45 are diagnostic, while
S100, MDM2  and CDK4 are used for the latter. Hematopoi-
etic tumors are distinguished by the presence of specific
CD markers. Malignant tumors of mesenchymal origin, such
as rhabdomyosarcoma or osteosarcoma, can be excluded
because of the lack of melanin and melanocyte marker expres-
sion, along with the expression of differentiation markers.1,6,23
7.7.  Teratoma
Definition: A tumor derived from germinal cells, with features
of differentiation toward at least two of the three germ cells
layers (namely, the ectoderm, mesoderm and endoderm).16,42
Epidemiology: The majority of these tumors, that is almost
90%, are found during the 1st year of life. They are rarely diag-
nosed later.specific marker for melanoma. Primary objective
magnification 20×.
Morphologic picture:  Macroscopically, lesions may be solid or
cystic. Histologically, they can be divided into mature (benign)
and immature (malignant) lesions. The tissue composition of
such tumors depends on the types of cells derived from the
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s between epithelial components (squamous, glandular,
uboidal or respiratory epithelium) and mesenchymal tissues
bone, cartilage, muscles and fat). Organ level differentiation is
ecognized by the formation of near-normal parts of different
rgans; skin being the most common of them.
Other important notes: Teratomas of the skull base found in
dults are usually malignant.
Differential diagnosis: As teratomas show differentiation
oward various tissues, such mixed composition gives patho-
ogic features that rarely raise diagnostic problems. The skull
ase is, however, an extremely rare location for such tumors,
hich are relatively common in the ovaries or testes.1,23,43
.8.  Chordomaefinition: A malignant tumor, probably arising from remnants
f the embryonal notochord.
Epidemiology: A rare bone tumor (accounting for less than
% of malignant bone tumors), it may develop from childhood
Table 3 – The genetic abnormalities found in skull base tumors
Tumors Involved genes Known c
Adenoid cystic
carcinoma
MYB, BCL2, ACCS, SNAI2,
KIT
Not yet estab
Cholesteatoma DEFB4A, KRT13 Not yet estab
Chondroma SDHD, SERPINA3 Multiple chan
Chondrosarcoma EXT1 8q24.11 




Craniopharyngioma CTNNB1, BRAF, MMP9 Multiple chan
Esthesioneuroblastoma EPOR −3p, +17q 
Gliomas IDH1, TP53, ERBB2 2q34, 17p13.1
Hemangioma KDR 2p13.3, 4q12, 




mucosa of the nose,
sinuses)
MALT1 18q21.32 
Melanoma malignum BRAF, KIT 1p36 
Meningioma
Skull base meningioma







TP53, ZMYND10 4p15.1-q12, 6
Neurilemmoma MYH8, VIM 22q11.23, 22q
Neuroma NF2 22q12.2 
Paraganglioma SDHD, SDHAF2, SDHB,
SDHC, SDHA
11q23.1, 1p36
Plasmocytoma IRF4, CCND1 22q11.23 
Rhabdomyosarcoma TTN, FHL2, PAX3 11p15.4, 1p36
Salivary glands tumors DENR, XIAP 8q12.1, 
Squamous cell
carcinoma
TNFRSF10B, ING1 8p21.3, 10q23
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until old age, with peak prevalence in the 5th and 6th decades.
Males and females are equally affected.
Morphologic picture:  Macroscopically, these are lobulated
masses with, on cross section, a myxoid and neural
appearance. On microscopic examination, two  cell types
are recognized. Elongated “chief” cells with an epithe-
lioid appearance, and large mucus-producing cells (Fig. 13).
On immunohistochemical examination they exhibit positive
reactions to: EMA, S100, HBME, and sometimes to keratins.
Other important notes: Chordomas develop in 3 main local-
izations: sacrococcygeal (most common, two  thirds of cases),
sphenooccipital (about quarter of cases) and vertebral.
Differential diagnosis: The diagnosis is made according to the
immunohistochemical profile, together with the presence of
areas of hyaline-type chondroid tissue. In differential diagno-
sis, chondrosarcoma must be taken into account. The differen-
tiation can be made based on localization, as chondromas do
not usually grow in the middle line. On immunohistochem-
ical studies, both chordoma and chondrosarcoma, are S100
positive, but the latter is EMA and keratin negative.1,18,44
.
ytogenetic features OMIM evidence of inheritance


















, 1q21, 11q13, 5p15 168000, 115310, 605373, 601650, 614165
605017
.13, 2q36.1, 13q14.11 268210, 268220
181030
.31, 13q34 275355
ges 273120 (pineal teratoma)
600634, 102200
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Fig. 13 – Chordoma is composed of elongated “chief” cells
with an epithelioid appearance, and large
mucus-producing cells. Hematoxylin and eosin staining.
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Secondary tumors developing in the area of the skull base are
most commonly derived from the breast, lung, kidney, gas-
trointestinal tract or prostate. In most cases, they reproduce
the morphology of the primary site tumors. For a precise diag-
nosis, relevant clinical data are needed. Metastases occur with
the same age distribution (plus a delay for systemic spread)
as with the primary lesions; thus, the peak incidence occurs
between the 5th and 8th decade.1,45
8.1.  Final  remarks
Skull base tumor biology is a rapidly expanding field that keeps
providing new opportunities for exploration. Many results
have come as a direct result of technological progress. At
present, we  know that tumors arise as a consequence of a
series of molecular events that fundamentally alter the nor-
mal  properties of cells. Altered cells are able to divide and grow
in the presence of signals that would normally inhibit that
growth. Heritable changes allow the tumor cell and its progeny
to divide and grow, to spread and to invade other tissues.
Years ago, the Human Genome Project brought signifi-
cant improvements to molecular biology and bioinformatics,
with databases such as NCBI or OMIM.  Currently, we can see
the development of the next generation of such techniques,
with deep sequencing and array-based methods ahead. Due
to these incredible improvements, it is worth reviewing sev-
eral molecular elements involved in skull-base tumor biology,
based on modern bioinformatic tools and databases. Table 3
shows genes, chromosomal abnormalities and syndromes
with a congenital background derived from several sources
of biological information. While this only partially covers the
requirements of clinical sciences, it may, nevertheless, initi-
ate a new approach to diagnosis, including histological data
and counseling procedures. The development of techniques
in molecular biology, and the use of databases, may soon be
useful in early diagnosis, long before tumors become visible.
1
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Adamska K, Kaźmierska J. Prospective study on dosimetric
comparison of helical tomotherapy and 3DCRT for
craniospinal irradiation – a single institution experience. Rep
Pract Oncol Radiother 2015;20:145–52.
4. Radner H, Katenkamp D, Reifenberger G, Deckert M,  Pietsch
T, Wiestler OD. New developments in the pathology of skull
base tumors. Virchows Arch 2001;438:321–35.
5. Shah J, Singh B. Jatin Shah’s head and neck surgery and oncology.
4th  ed. Elsevier; 2012.
6. Calzada AP, Abemayor E, Wong DTW. Molecular pathology of
head and neck cancer. In: Cheng L, Eble JN, editors. Molecular
surgical pathology. Springer; 2013.
7. Larynx and trachea.Fletcher CDM, editor. Diagnostic
histopathology of tumors.  3rd ed. Churchill Livingstone; 2007.
8. Kassam AB, Prevedello DM, Carrau RL, et al. Endoscopic
endonasal skull base surgery: analysis of complications in
the authors’ initial 800 patients. J Neurosurg 2011;114:1544–68.
9. Safdari Y, Khalili M, Farajnia S, Asgharzadeh M, Yazdani Y,
Sadeghi M. Recent advances in head and neck squamous cell
carcinoma – a review. Clin Biochem 2014;47:1195–202.
0. Burduk PK, Bodnar M, Sawicki P, et al. Expression of
metalloproteinases 2 and 9 and tissue inhibitors 1 and 2 as
predictors of lymph node metastases in oropharyngeal
squamous cell carcinoma. Head Neck 2015;37:418–22.
1. emedicine.medscape.com/article/250237-overview [last
accessed 22.09.14].
2. Teoh JW,  Yunus RM, Hassan F, Ghazali N, Abidin ZAZ.
Nasopharyngeal carcinoma in dermatomyositis patients: a
10-year retrospective review in Hospital Selayang, Malaysia.
Rep Pract Oncol Radiother J Gt Cancer Cent Pozn Polish Soc Radiat
Oncol 2014;19:332–6.
3. Chua MLK, Wee JTS, Hui EP, Chan ATC. Nasopharyngeal
carcinoma. Lancet 2015. Online.
4. Lee AWM, Ma BBY, Ng WT, Chan ATC. Management of
nasopharyngeal carcinoma: current practice and future
perspective. J Clin Oncol 2015;33:3356–64.
5. Prabhu SS, Demonte F. Treatment of skull base tumors. Curr6. Tsai EC, Santoreneos S, Rutka JT. Tumors of the skull base in































reports of practical oncology and 
7. Negoto T, Sakata K, Aoki T, et al. Sequential pathological
changes during malignant transformation of a
craniopharyngioma: a case report and review of the
literature. Surg Neurol Int 2015;6:50.
8. www.pathologyoutlines.com [last attempt 24.10.14].
9. Fernandez-Miranda JC, Gardner PA, Snyderman CH, et al.
Craniopharyngioma: a pathologic, clinical, and surgical
review. Head Neck 2012;34:1036–44.
0. Thompson LDR. Head and neck pathology. 2nd ed. Elsevier;
2013.
1. Dillon PM, Chakraborty S, Moskaluk CA, Joshi PJ, Thomas CY.
Adenoid cystic carcinoma: a review of recent advances,
molecular targets, and clinical trials. Head Neck 2014. Online.
2. Wierzchowska M, Bodnar M, Burduk PK, Kaźmierczak W,
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